Biochemical assay for amyloid β deposits to distinguish Alzheimer's disease from other dementias

Clinica Chimica Acta

Volumn 280, Issue 1-2, 1999, Pages 147-159

  Kaplan, Batia ^a   Haroutunian, Vahram ^b   Koudinov, Alexei ^c   Patael, Yael ^a   Pras, Mordechai ^a   Gallo, Gloria ^d  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Biochemical assay; Western blotting

Indexed keywords

ACETONITRILE; AMYLOID BETA PROTEIN; MONOCLONAL ANTIBODY; TRIFLUOROACETIC ACID;

ALZHEIMER DISEASE; ASSAY; BRAIN TISSUE; CLINICAL ARTICLE; COMPUTER PROGRAM; COMPUTER SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; MEMBRANE; PRIORITY JOURNAL; PROTEIN DETERMINATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID; BLOTTING, WESTERN; BRAIN; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 0032966355     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00190-9     Document Type: Conference Paper

References (43)

1. Wisniewski H.M., Kozlowski P.B. Evidence for blood-barrier changes in senile dementia of the Alzheimer type. Ann NY Acad Sci. 396:1982;119-129.
2. Frangione B, Wisniewski T, Ghiso J. Alzheimer's disease and amyloid β. In: Kisilevsky R, Benson MD, Frangione B, et al., editor. Amyloid and Amyloidosis, New York: Pantheon Publishing 1993:310-5.
3. Wisniewski T., Frangione B. Molecular biology of brain aging and neurodegenerative disorders. Acta Neurobiol Exp (Warsz). 56:1996;267-279.
4. Wisniewski T., Ghiso J., Frangione B. Biology of A beta amyloid in Alzheimer's disease. Neurobiol Dis. 4:1997;313-328.
5. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 120:1984;885-890.
6. Masters C.L., Simms G., Weinman N.A., Muthaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc Natl Acad Sci USA. 82:1985;4245-4249.
7. Selkoe D.J., Abraham C.R., Podlisny M.B., Duffy L.K. Isolation of low molecular weight proteins from amyloid plaque deposits in Alzheimer's disease. J Neurochem. 46:1986;1820-1834.
8. Kaplan B., German G., Pras M. Isolation and characterization of amyloid proteins from milligram amounts of amyloid-containing tissue. J Liq Chromatogr. 16:1993;2249-2268.
9. Kaplan B., Yakar S., Kumar A., Pras M., Gallo G. Immunochemical characterization of amyloid in diagnostic biopsy tissues. Amyloid: Int J Exp Clin Invest. 4:1996;80-86.
10. Kaplan B., Vidal R., Kumar A., Ghiso J., Frangione B., Gallo G. Amino- terminal identity of co-existent amyloid and non-amyloid immunoglobulin κ light chain deposits. A human disease to study alterations of protein conformation. Clin Exp Immunol. 110:1997;472-478.
11. Kaplan B, Martin B, Yakar S, Pras M, Wisniewski T, Ghiso J, Frangione B, Gallo G. A simple procedure of immunochemical detection of amyloid β proteins using milligram amounts of brain tissues of patients with Alzheimer's disease. In: Fisher A, Yoshida M and Hanin I, editors. Progress in Alzheimer's and Parkinson's Diseases. New York: Plenum Press, 1998:823-8.
12. Schumaker V, Puppione D. Preparation of plasma lipoproteins. In: Segrest J, Alberts J, editors. Methods in Enzymology, New York: Academic Press, 1986;128:155-70.
13. Laemmli U.K. Cleavage of structural proteins during assembly of the head of the bacteriophage T4. Nature. 227:1970;680-682.
14. Towbin J., Stachelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci USA. 76:1979;4350-4354.
15. Kim K.S., Miller D.L., Sapienza V.J., Chen C.M.J., Bai C., Grungke-Iqbal I., Currie J., Wisniewski H.M. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular peptide. Neurosci Commun. 2:1988;121-130.
16. Frucht S.J., Koo E.H. β-Amyloid protein is higher in Alzheimer's disease: description of a quantitative biochemical assay. J Neuropathol Exp Neurol. 52:1993;640-647.
17. Permanne B., Buee L., David J.P., Fallet-Bianko C., Di Menza C., Delacourte A. Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay. Brain Res. 685:1995;154-162.
18. Mori H., Takio K., Ogawara M., Selkoe D. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J Biol Chem. 267:1992;17082-17086.
19. Harigaya Y., Shoji M., Kawarabayashi T., Kanai M., Nakamura T., Iizuka T., Igeta Y., Saido T.C., Sahara N., Mori H., Hirai S. Modified amyloid β protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease. Biochem Biophys Res Commun. 211:1995;1015-1022.
20. Yanagisawa K., Odaka A., Suzuki N., Ihara Y. GM1 ganglioside-bound amyloid β (Aβ): a possible form of preamyloid in Alzheimer's disease. Nature. 10:1995;1062-1066.
21. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
22. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 135:1992;235-238.
23. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
24. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Ros B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hullette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Arch Neurol. 43:1993;1467-1472.
25. van Duijn C.M., de Knijff P., Cruts M., Wehnert A., Havekes L.M., Hofman A., van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 7:1994;74-77.
26. Maetzger R.E., LaDu-Pan J.B., Getz G.S., Frail D.E., Falduto M.T. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J Neuropathol Exp Neurol. 55:1996;372-380.
27. Pirttila T., Soininen H., Heinonen O., Lehtimaki T., Bogdanovic N., Paljarvi L., Kosunen O., Winblad B., Riekkinen S.P., Wisniewski H.M., Metha P.D. Apolipoprotein E (apoE) levels in brains from Alzheimer's disease patients and controls. Brain Res. 722:1997;71-77.
28. Oyama F., Shimada H., Oyama R., Ihara Y. Alzheimer's pathologies and related gene expression in the aged population. Mol Brain Res. 29:1995;92-95.
29. Wisniewski T., Lalowski M., Golabek A., Voge T., Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet. 345:1995;956-958.
30. Cohen M.L., Golde T.E., Usiak M.F., Younkin L.H., Younkin S.G. In situ hybridisation of nucleus basalis neurons shows increased β amyloid mRNA in Alzheimer's disease. Proc Natl Acad Sci USA. 85:1998;1227-1231.
31. Higgins G.A., Lewis D.A., Bahmangar S., Goldgaber D., Gajdusek D.C., Young W.G., Morrison J.H., Wilson M.C. Differential regulation of amyloid β protein expression within hippocampal neuronal subpopulation in Alzheimer's disease. Proc Natl Acad Sci USA. 85:1988;1297-1301.
32. Goodison K.L., Parhad I.M., White C.L., Sima A.A.F., Clark A.W. Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease. J Neuropathol Exp Neurol. 52:1993;192-198.
33. Harrison P.J., Barton A.J.L., Procter A.W., Bowen D.M., Pearson R.C.A. The effects of Alzheimer's disease, other dementias, and premortem course on β-amyloid precursor protein messenger RNA in frontal cortex. J Neurochem. 62:1994;635-644.
34. Johnston J., Norgren S., Ravid R., Wasco W., Winblad B., Lannfelt L., Cowburn F. Quatification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains. Mol Brain Res. 43:1996;85-95.
35. DiLuca M., Pastorino L., Cattabeni F., Zanardi R., Scarone S., Racagni G., Smeraldi E., Perez J. Abnormal pattern of platelet APP isoforms in Alzheimer's disease and Down syndrome. Arch Neurol. 53:1996;1162-1166.
36. Rosenberg R.N., Baskin F., Fosmire J.A., Risser R., Adams A., Svetlik D., Honig L.S., Cullum M., Weiner M.F. Altered amyloid protein processing in platelets of patients with Alzheimer's disease. Arch Neurol. 54:1997;139-144.
37. Selkoe D.J., Berman Podlisny M., Joachim C.L., Vickers E.A., Lee G., Fritz L.C., Oltersdorf T. β-Amyloid precursor protein of Alzheimer's disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci USA. 85:1988;7341-7345.
38. Tagliavini F., Ghiso J., Timmers W.F., Giaccone G., Bugiani O., Frangione B. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. Lab Invest. 62:1990;761-767.
39. Tamaoka A., Kalaria R.N., Lieberburg I., Selkoe D.J. Identification of a stable fragment of the Alzheimer amyloid precursor containing the β-protein in brain microvessels. Proc Natl Acad Sci USA. 89:1992;1345-1349.
40. Ghiso J., Rostagno A., Gardella J.E., Liem L., Gorevic P.D., Frangione B. A 109-amino-acid C-terminal fragment of Alzheimer's disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem J. 388:1992;1053-1059.
41. Nordstedt C., Gandy S.E., Alafuzoff I., Caporaso G.L., Iverfeldt K., Grebb J.A., Winblad G., Greengard P. Alzheimer β/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc Natl Acad Sci USA. 88:1991;8910-8914.
42. Estus S., Golde T.E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X., Tabira T., Greenberg B.D., Younkin S.G. Potentially amyloidogenic, carboxyl-terminal derivates of the amyloid protein precursor. Science. 255:1992;726-728.
43. Suh Y.-H. An etiological role of amyloidogenic carboxyl-terminal fragments of the β-amyloid precursor protein in Alzheimer's disease. J Neurochem. 68:1997;1781-1791.